Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)
1 other identifier
interventional
845
1 country
4
Brief Summary
The project aims to improve patient safety, reduce barriers to the implementation of current guideline recommendations, reduce workload in clinics, increase efficiency in work processes and close gaps in care. Subprojects regarding delirium are implementes as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2024
CompletedStudy Start
First participant enrolled
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
June 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
ExpectedMay 4, 2026
April 1, 2026
1.6 years
May 23, 2024
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Guideline adherence
Guideline adherence: proportion of guideline recommendations fulfilled per patient in the first five postoperative days. The guideline adherence rate up to postoperative day 5 (or earlier if the patient has already been discharged) is calculated as a simple division: Number of recommendations fulfilled by number of all recommendations (N=6). A guideline adherence rate of at least 4 out of 6 points (67%) per patient is considered clinically sufficient.
Up to five days
Postperative delirium- free days
Number of postoperative delirium- free days within 5 days postoperatively per patient.
Up to five days
Secondary Outcomes (50)
Causes of delirium
Up to seven days
Changes of Electroencephalography
Participants will be followed up until the end of the operation, an expected average of 60 minutes
Blood pressure
Participants will be followed up until the end of hospital stay, an expected average of 7 days
Pulse
Participants will be followed up until the end of hospital stay, an expected average of 7 days
Heart rhythm
Participants will be followed up until the end of hospital stay, an expected average of 7 days
- +45 more secondary outcomes
Study Arms (2)
Control phase
NO INTERVENTIONControl phase: in this phase, all study patients receive the standard therapy of the respective study center.
Intervention phase
EXPERIMENTALIn this phase, the intervention with Digi-POD is made available as Clinical Decision Support System. The intervention consists of providing patients, relatives and caregivers with Digi-POD decision support for the prevention of delirium and treatment decisions for delirium in accordance with the recommendations from the guidelines in addition to the standard therapy of the respective study center.
Interventions
To this phase, patient data is automated and systematically analyzed in order to derive decision support based on current evidence and make it available to Digi-POD users (patients, relatives, nursing staff, doctors, other healthcare professionals).
Eligibility Criteria
You may qualify if:
- Age ≥ 70 years
- Male and female patients
- Patients who are insured through statutory health insurance
- Operation (elective)
You may not qualify if:
- Insufficient language skills
- Moribund patients
- Study relatives
- Age ≥ 18 years
- Male and female relatives
- Insufficient language skills
- No consent for data entry
- Substudy of the Charité - University Berlin:
- \- All inpatients ≥ 18 years of age who have undergone delirium screening with a validated delirium screening instrument
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruhr University of Bochumcollaborator
- Charite University, Berlin, Germanylead
- BARMERcollaborator
- Technische Universität Berlincollaborator
- Freie Universität Berlincollaborator
Study Sites (4)
Institut für Anästhesiologie und Schmerztherapie-Herz- und Diabeteszentrum NRW- Universitätsklinik der Ruhr-Universität Bochum
Bad Oeynhausen, Bochum, 32545, Germany
Department of Anaesthesiolgy and Intensive Care Medicine CCM/CVK, Charite- University Berlin
Berlin, 13355, Germany
CARITAS Klinik Maria Heimsuchung
Berlin, Germany
Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH
Berlin, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)
Study Record Dates
First Submitted
May 23, 2024
First Posted
June 6, 2024
Study Start
June 3, 2024
Primary Completion
January 15, 2026
Study Completion (Estimated)
July 31, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share